SPY420.86+5.94 1.43%
DIA338.78+5.82 1.75%
IXIC14,141.48+111.10 0.79%

Intersect ENT Q1 EPS $(0.61) Misses $(0.42) Estimate, Sales $24.30M Beat $23.54M Estimate

Intersect ENT (NASDAQ:XENT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.42) by 45.24 percent. This is a 12.96 percent decrease over losses of $(0.54) per share from

05/10/2021 07:23
Intersect ENT (NASDAQ:XENT) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.42) by 45.24 percent. This is a 12.96 percent decrease over losses of $(0.54) per share from the same period last year. The company reported quarterly sales of $24.30 million which beat the analyst consensus estimate of $23.54 million by 3.23 percent. This is a 22.57 percent increase over sales of $19.83 million the same period last year.